Serina Therapeutics, Inc.
SER
$2.57
$0.072.80%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -6.36M | -6.90M | -3.34M | -4.59M | -6.45M |
| Total Depreciation and Amortization | 18.00K | 18.00K | 24.00K | 16.00K | 16.00K |
| Total Amortization of Deferred Charges | 77.00K | 64.00K | 58.00K | -- | -- |
| Total Other Non-Cash Items | 831.00K | 1.74M | -1.69M | -677.00K | 1.98M |
| Change in Net Operating Assets | -1.25M | 508.00K | -1.09M | 1.40M | 706.00K |
| Cash from Operations | -6.68M | -4.57M | -6.03M | -3.85M | -3.75M |
| Capital Expenditure | -28.00K | -25.00K | 0.00 | -13.00K | -46.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -28.00K | -25.00K | 0.00 | -13.00K | -46.00K |
| Total Debt Issued | -- | -- | 0.00 | 4.91M | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5.20M | 26.06M | 5.40M | 1.53M | 630.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | 0.00 | 0.00 | 4.94M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -4.92M | 0.00 | 0.00 |
| Cash from Financing | 5.20M | 26.06M | 481.00K | 6.44M | 5.57M |
| Foreign Exchange rate Adjustments | 8.00K | 6.00K | -12.00K | -2.00K | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.50M | 21.47M | -5.56M | 2.58M | 1.77M |